Seminars in Nephrology
Volume 25, Issue 1 , Pages 32-38 , January 2005

Uric acid and hypertension in adolescents

  • Daniel I. Feig

      Affiliations

    • Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX.
    • Corresponding Author InformationAddress reprint requests to Daniel I. Feig, Department of Pediatrics, Renal Section, Baylor College of Medicine. 1102 Bates St, MC3-2482, Houston, TX 77030.

References 

  1. Furner SE , Maurer J , Rosenberg H . Health data on older Americans: United States, 1992 . Mortality. Vital Health Stat . 1993;3:77–112
  2. Burt VL , Whelton P , Roccella EJ , et al.   Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991 . Hypertension . 1995;25:305–313
  3. MacMahon S , Neal B , Rodgers A . Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease . Schweiz Med Wochenschr . 1995;125:2479–2486
  4. Klag MJ , Whelton PK , Randall BL , et al.   Blood pressure and end-stage renal disease in men . N Engl J Med . 1996;334:13–18
  5. Coresh J , Longenecker JC , Miller ER , et al.   Epidemiology of cardiovascular risk factors in chronic renal disease . J Am Soc Nephrol . 1998;9:S24–S30
  6. Coresh J , Wei GL , McQuillan G , et al.   Prevalence of high blood pressure and elevated serum creatinine level in the United States (Findings from the third National Health and Nutrition Examination Survey (1988–1994)) . Arch Intern Med . 2001;161:1207–1216
  7. Multiple Risk Factor Intervention Trial Research Group . Multiple risk factor intervention trial. Risk factor changes and mortality results . JAMA . 1982;248:1465–1477
  8. Pontremoli R , Viazzi F , Ravera M , et al.   Long term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension . J Nephrol . 2001;14:19–26
  9. Taguchi J , Freis ED . Partial reduction of blood pressure and prevention of complications in hypertension . N Engl J Med . 1974;291:329–331
  10. Zinner SH , Rosner B , Oh W , et al.   Significance of blood pressure in infancy. Familial aggregation and predictive effect on later blood pressure . Hypertension . 1985;7:411–416
  11. Lauer RM , Clarke WR . Childhood risk factors for high adult blood pressure (the Muscatine study) . Pediatrics . 1989;84:633–641
  12. Shear CL , Burke GL , Freedman DS , et al.   Value of childhood blood pressure measurements and family history in predicting future blood pressure status (Results from 8 years of follow-up in the Bogalusa Heart Study) . Pediatrics . 1986;77:862–869
  13. Burke GL , Arcilla RA , Culpepper WS , et al.   Blood pressure and echocardiographic measures in children (The Bogalusa Heart Study) . Circulation . 1987;75:106–114
  14. Daniels SD , Meyer RA , Loggie JM . Determinants of cardiac involvement in children and adolescents with essential hypertension . Circulation . 1990;82:1243–1248
  15. Pontremoli R , Nicolella C , Viazzi F , et al.   Microalbuminuria is an early marker of target organ damage in essential hypertension . Am J Hypertens . 1998;11:430–438
  16. Lande MB , Kaczorowski JM , Auinger P , et al.   Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States . J Pediatr . 2003;143:720–724
  17. Kavey RE , Daniels SR , Lauer RM , et al.   American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood . J Pediatr . 2003;142:368–372
  18. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents . Update on the 1987 task force report on high blood pressure in children and adolescents (A working group report from the National High Blood Pressure Education Program) . Pediatrics . 1996;98:649–658
  19. Task Force on Blood Pressure Control in Children . Report of the second task force on blood pressure control in children—1987. National Heart, Lung, and Blood Institute, Bethesda, Maryland . Pediatrics . 1987;79:1–25
  20. Sorof JM , Turner J , Martin DS , et al.   Cardiovascular risk factors and sequelae in hypertensive children identified by referral versus school-based screening . Hypertension . 2004;43:214–218
  21. Soergel M , Kirschstein M , Busch C , et al.   Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents (A multicenter trial including 1141 subjects) . J Pediatr . 1997;130:178–184
  22. Hornsby JL , Mongan PF , Taylor AT , et al.   ‘White coat’ hypertension in children . J Fam Pract . 1991;33:617–623
  23. Palatini P , Mormino P , Santonastaso M , et al.   Ambulatory blood pressure predicts end-organ damage only in subjects with reproducible recordings. HARVEST study investigators. Hypertension and Ambulatory Recording Venetia Study . J Hypertens . 1999;17:465–473
  24. Verdecchia P , Schillaci G , Guerrieri M , et al.   Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension . Circulation . 1990;81:528–536
  25. Zweiker R , Eber B , Schumacher M , et al.   “Non-dipping” related to cardiovascular events in essential hypertensive patients . Acta Med Austriaca . 1994;21:86–89
  26. Bartosh SM , Aronson AJ . Childhood hypertension. An update on etiology, diagnosis, and treatment . Pediatr Clin North Am . 1999;46:235–252
  27. Gruskin AB , Dabbagh S , Fleishcmann LF , et al.   Mechanisms of hypertension in childhood diseases . In:  Barratt TM ,  Avner ED ,  Harmon W editor. Pediatric Nephrology . (ed 4). Baltimore: Williams & Wilkins; 1999;p. 987–1006
  28. Swinford RD , Ingelfinger JR . Evaluation of hypertension in childhood diseases . In:  Barratt TM ,  Avner ED ,  Harmon W editor. Pediatric Nephrology . (ed 4). Baltimore: Williams & Wilkins; 1999;p. 1007–1030
  29. Norwood VF . Hypertension . Pediatr Rev . 2002;23:197–208
  30. Masding MG , Jones JR , Bartley E , et al.   Assessment of blood pressure in patients with type 2 diabetes (Comparison between home blood pressure monitoring, clinic blood pressure measurement and 24-h ambulatory blood pressure monitoring) . Diabet Med . 2001;18:431–437
  31. Sorof JM , Poffenbarger T , Franco K , et al.   Evaluation of white coat hypertension in children (Importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension) . Am J Hypertens . 2001;14:855–860
  32. Mohamed FA . On chronic Bright’s disease, and its essential symptoms . Lancet . 1879;1:399–401
  33. Cannon PJ , Stason WB , Demartini FE , et al.   Hyperuricemia in primary and renal hypertension . N Engl J Med . 1966;275:457–464
  34. Kinsey D , Walther R , Sise HS , et al.   Incidence of hyperuricemia in 400 hypertensive subjects . Circulation . 1961;24:972–973
  35. Klein R , Klein BE , Cornoni JC , et al.   Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia . Arch Intern Med . 1973;132:401–410
  36. Selby JV , Friedman GD , Quesenberry CP . Precursors of essential hypertension (Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries) . Am J Epidemiol . 1990;131:1017–1027
  37. Jossa F , Farinaro E , Panico S , et al.   Serum uric acid and hypertension (The Olivetti heart study) . J Hum Hypertens . 1994;8:677–681
  38. Rovda Iu I , Kazakova LM , Plaksina EA . [Parameters of uric acid metabolism in healthy children and in patients with arterial hypertension] . Pediatriia . 1990;8:19–22
  39. Torok E , Gyarfas I , Csukas M . Factors associated with stable high blood pressure in adolescents . J Hypertens Suppl . 1985;3(suppl 3):S389–S390
  40. Gruskin AB . The adolescent with essential hypertension . Am J Kidney Dis . 1985;6:86–90
  41. Feig DI , Johnson RJ . Hyperuricemia in childhood primary hypertension . Hypertension . 2003;42:247–252
  42. Goldstein HS , Manowitz P . Relation between serum uric acid and blood pressure in adolescents . Ann Hum Biol . 1993;20:423–431
  43. Brand FN , McGee DL , Kannel WB , et al.   Hyperuricemia as a risk factor of coronary heart disease (The Framingham Study) . Am J Epidemiol . 1985;121:11–18
  44. Kannel WB . Metabolic risk factors for coronary heart disease in women (Perspective from the Framingham Study) . Am Heart J . 1987;114:413–419
  45. Ruilope LM , Rodicio JL . Renal surrogates in essential hypertension . Clin Exp Hypertens . 1999;21:609–614
  46. Hochberg MC , Thomas J , Thomas DJ , et al.   Racial differences in the incidence of gout. The role of hypertension . Arthritis Rheum . 1995;38:628–632
  47. Hall AP , Barry PE , Dawber TR , et al.   Epidemiology of gout and hyperuricemia. A long-term population study . Am J Med . 1967;42:27–37
  48. Reaven GM . The kidney (An unwilling accomplice in syndrome X) . Am J Kidney Dis . 1997;30:928–931
  49. Wu X , Wakamiya M , Vaishnav S , et al.   Hyperuricemia and urate nephropathy in urate oxidase-deficient mice . Proc Natl Acad Sci U S A . 1994;91:742–746
  50. Stavric B , Johnson WJ , Grice HC . Uric acid nephropathy (An experimental model) . Proc Soc Exp Biol Med . 1969;130:512–516
  51. Mazzali M , Hughes J , Kim YG , et al.   Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism . Hypertension . 2001;38:1101–1106
  52. Mazzali M , Kanellis J , Han L , et al.   Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism . Am J Physiol . 2002;282:F991–F997
  53. Watanabe S , Kang DH , Feng L , et al.   Uric acid hominoid evolution and the pathogenesis of salt-sensitivity . Hypertension . 2002;40:355–360
  54. Kang DH , Nakagawa T , Feng L , et al.   A role for uric acid in the progression of renal disease . J Am Soc Nephrol . 2002;13:2888–2897
  55. Harris RC , Breyer MD . Physiological regulation of cyclooxygenase-2 in the kidney . Am J Physiol . 2001;281:F1–F11
  56. Feig DI , Nakagawa T , Karumanchi SA , et al.   Hypothesis (Uric acid, nephron number and the pathogenesis of essential hypertension) . Kidney Int . 2004;66:281–287
  57. Dahl LK , Heine M . Primary role of renal homografts in setting chronic blood pressure levels in rats . Circ Res . 1975;36:692–696
  58. Sommers S , Relman R , Smithwick R . Histologic studies of kidney biopsy specimens from patients with hypertension . Am J Pathol . 1958;34:685–715
  59. Moritz A , Oldt M . Ateriolar sclerosis in hypertensive and nonhypertensive individuals . Am J Pathol . 1937;13:679–728
  60. Tracy RE . Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites . Semin Nephrol . 1996;16:126–133
  61. Tracy RE , Berenson G , Wattigney W , et al.   The evolution of benign arterionephrosclerosis from age 6 to 70 years . Am J Pathol . 1990;136:429–439
  62. Barker DJ . The fetal origins of adult hypertension . J Hypertens Suppl . 1992;10:S39–S44
  63. Barker DJ , Osmond C , Golding J , et al.   Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease . BMJ . 1989;298:564–567
  64. Falkner B , Hulman S , Kushner H . Effect of birth weight on blood pressure and body size in early adolescence . Hypertension . 2004;43:203–207
  65. Keller J , Zimmer G , Mall G , et al.   Nephron number in patients with primary hypertension . N Engl J Med . 2003;348:101–118
  66. Anderson EA , Sinkey CA , Lawton WJ , et al.   Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings . Hypertension . 1989;14:177–183
  67. Esler M , Turbott J , Schwarz R , et al.   Differing noradrenaline kinetics in essential hypertension and depressive illness, two diseases in which the plasma concentration of noradrenaline is sometimes elevated . Clin Exp Pharmacol Physiol . 1981;8:525–530
  68. Matsukawa T , Gotoh E , Hasegawa O , et al.   Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension . J Hypertens . 1991;9:537–542
  69. Perondi R , Saino A , Tio RA , et al.   ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease . Circulation . 1992;85:2004–2013
  70. Panza JA , Casino PR , Kilcoyne CM , et al.   Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension . Circulation . 1993;87:1468–1474
  71. Panza JA , Casino PR , Kilcoyne CM , et al.   Impaired endothelium-dependent vasodilation in patients with essential hypertension (Evidence that the abnormality is not at the muscarinic receptor level) . J Am Coll Cardiol . 1994;23:1610–1616
  72. Panza JA , Garcia CE , Kilcoyne CM , et al.   Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway . Circulation . 1995;91:1732–1738
  73. Panza JA , Quyyumi AA , Brush JE , et al.   Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension . N Engl J Med . 1990;323:22–27
  74. Johnson RJ , Herrera-Acosta J , Schreiner GF , et al.   Subtle acquired renal injury as a mechanism of salt-sensitive hypertension . N Engl J Med . 2002;346:913–923
  75. Johnson RJ , Rodriguez-Iturbe B , Schreiner GF , et al.   Hypertension (A microvascular and tubulointerstitial disease) . J Hypertens Suppl . 2002;20:S1–S7
  76. Kang DH , Nakagawa T , Feng L , et al.   Nitric oxide modulates vascular disease in the remnant kidney model . Am J Pathol . 2002;161:239–248
  77. Furberg CD , Wright JT , Davis BR , et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic   The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) . JAMA . 2002;288:2981–2997
  78. Wing LM , Reid CM , Ryan P , et al.   A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly . N Engl J Med . 2003;348:583–592

 Supported by National Institutes of Health grant DK-064587.

PII: S0270-9295(04)00149-4

doi: 10.1016/j.semnephrol.2004.09.006

Seminars in Nephrology
Volume 25, Issue 1 , Pages 32-38 , January 2005

Article Tools

* Image Usage & Resolution